GlassScriptPhysician profile
Yukiko Oe
NPI 1992020069
$1,197.58
in general payments reported to CMS, 2019-2025
19 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.36 · 2020: $14.89 · 2021: $198 · 2022: $351 · 2023: $149 · 2024: $246 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.58 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $419.03 | 2021-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $167.73 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $124.23 | 2024 | Lumryz |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Grifols USA, LLC | $61.76 | 2022-2023 | Prolastin-C Liquid |
| Pulmonx Corporation | $59.98 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $46.71 | 2022-2023 | Dupixent |
| United Therapeutics Corporation | $31.94 | 2021-2022 | |
| Genzyme Corporation | $27.17 | 2022 | |
| Vapotherm INC | $24.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.36 | 2019 | |
| Baxter Healthcare | $19.73 | 2022 | |
| Covis Pharma Gmbh | $16.43 | 2022 | |
| Harmony Biosciences LLC | $15.00 | 2021 | |
| Philips North America LLC | $15.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.89 | 2020 | |
| Insmed, INC. | $14.28 | 2022 | |
| Mylan Specialty L.P. | $13.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yukiko Oe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.